| Sarvalakshmi Kurella, MD | |
|
6101 Redwood Square Ctr Ste 200, Centreville, VA 20121-4267 | |
| (703) 631-0331 | |
| (703) 631-2573 |
| Full Name | Sarvalakshmi Kurella |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 31 Years |
| Location | 6101 Redwood Square Ctr Ste 200, Centreville, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265672323 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 238622 (Massachusetts) | Secondary |
| 207R00000X | Internal Medicine | 0101274933 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Home Health Llc | Fairfax, VA | Home health agency |
| Umass Memorial Medical Center/university Campus | Worcester, MA | Hospital |
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Inova Fair Oaks Hospital | Fairfax, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inova Physician Partners Llc | 2466581772 | 300 |
News Archive
The Regence Foundation has announced a new award that recognizes leadership in palliative care, a specialized field of health care that relieves suffering and improves quality of life for patients with advanced illness.
Takeda Pharmaceuticals International GmbH today announced further expansion of its commercial platform with the establishment of its wholly-owned subsidiary in Israel. Together with Algeria, Ecuador, Peru, Singapore and Vietnam, Israel is the sixth sales entity Takeda has opened this year to reinforce its platform in growth markets.
Leica Microsystems, world-leading provider of Total Digital Pathology solutions, and Indica Labs, developing excellence in image analysis for Digital Pathology, today announce the integration of Indica Labs' advanced image analysis algorithm portfolio into Leica Microsystems digital pathology solution.
A new report from the American Cancer Society says a large proportion of the 141,000 cases and 49,000 deaths from colorectal cancer expected in the United States this year could be prevented by increasing the use of established screening tests and by applying existing knowledge about colorectal cancer prevention.
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer.
› Verified 7 days ago
| Entity Name | Inova Physician Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215264916 PECOS PAC ID: 2466581772 Enrollment ID: O20100525000846 |
News Archive
The Regence Foundation has announced a new award that recognizes leadership in palliative care, a specialized field of health care that relieves suffering and improves quality of life for patients with advanced illness.
Takeda Pharmaceuticals International GmbH today announced further expansion of its commercial platform with the establishment of its wholly-owned subsidiary in Israel. Together with Algeria, Ecuador, Peru, Singapore and Vietnam, Israel is the sixth sales entity Takeda has opened this year to reinforce its platform in growth markets.
Leica Microsystems, world-leading provider of Total Digital Pathology solutions, and Indica Labs, developing excellence in image analysis for Digital Pathology, today announce the integration of Indica Labs' advanced image analysis algorithm portfolio into Leica Microsystems digital pathology solution.
A new report from the American Cancer Society says a large proportion of the 141,000 cases and 49,000 deaths from colorectal cancer expected in the United States this year could be prevented by increasing the use of established screening tests and by applying existing knowledge about colorectal cancer prevention.
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarvalakshmi Kurella, MD Po Box 37189, Baltimore, MD 21297-3189 Ph: (571) 423-5699 | Sarvalakshmi Kurella, MD 6101 Redwood Square Ctr Ste 200, Centreville, VA 20121-4267 Ph: (703) 631-0331 |
News Archive
The Regence Foundation has announced a new award that recognizes leadership in palliative care, a specialized field of health care that relieves suffering and improves quality of life for patients with advanced illness.
Takeda Pharmaceuticals International GmbH today announced further expansion of its commercial platform with the establishment of its wholly-owned subsidiary in Israel. Together with Algeria, Ecuador, Peru, Singapore and Vietnam, Israel is the sixth sales entity Takeda has opened this year to reinforce its platform in growth markets.
Leica Microsystems, world-leading provider of Total Digital Pathology solutions, and Indica Labs, developing excellence in image analysis for Digital Pathology, today announce the integration of Indica Labs' advanced image analysis algorithm portfolio into Leica Microsystems digital pathology solution.
A new report from the American Cancer Society says a large proportion of the 141,000 cases and 49,000 deaths from colorectal cancer expected in the United States this year could be prevented by increasing the use of established screening tests and by applying existing knowledge about colorectal cancer prevention.
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer.
› Verified 7 days ago
Dr. Sugkee Youn, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13880 Braddock Rd Ste 107, Centreville, VA 20121 Phone: 703-965-0180 Fax: 703-266-9003 | |
Dr. Henry Hyung Back Rhee, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 13890 Braddock Rd Ste 206, Centreville, VA 20121 Phone: 703-758-2664 Fax: 703-758-2668 | |
Dr. Scott I Bell, M.D., PHD. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6211 Centreville Rd, Suite 700, Centreville, VA 20121 Phone: 703-222-0002 Fax: 703-449-9890 | |
Ashok Kumar Ahuja, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 13533 Ann Grigsby Cir, Centreville, VA 20120 Phone: 703-988-9691 | |
Dr. Thomas R Graziano, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 6211 Centreville Rd, Suite 700, Centreville, VA 20121 Phone: 703-222-0002 Fax: 703-449-9890 | |
Dr. Frederick F Lennon, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 6211 Centreville Rd, Suite 700, Centreville, VA 20121 Phone: 703-222-0002 Fax: 703-449-9890 |